AVITA Medical (RCEL) Cash & Current Investments (2018 - 2025)

AVITA Medical (RCEL) has 8 years of Cash & Current Investments data on file, last reported at $18.2 million in Q4 2025.

• For the quarter ending Q4 2025, Cash & Current Investments fell 49.32% year-over-year to $18.2 million; the trailing twelve-month figure through Dec 2025 stood at $18.2 million (down 49.32% YoY), and the FY2025 full-year result was $18.2 million, down 49.32% from the prior year.
• Cash & Current Investments for Q4 2025 stood at $18.2 million, up from $16.2 million in the prior quarter.
• Across five years, Cash & Current Investments topped out at $115.1 million in Q1 2021 and bottomed at $14.1 million in Q2 2025.
• The 5-year median for Cash & Current Investments is $69.2 million (2023), against an average of $63.0 million.
• The widest annual swing landed in 2021, when Cash & Current Investments soared 50.25%; it then slumped 73.96% in 2025.
• A 5-year view of Cash & Current Investments shows it stood at $85.4 million in 2021, then retreated by 7.05% to $79.3 million in 2022, then slipped by 1.26% to $78.3 million in 2023, then plunged by 54.19% to $35.9 million in 2024, then slumped by 49.32% to $18.2 million in 2025.
• The last three Cash & Current Investments figures came in at $18.2 million (Q4 2025), $16.2 million (Q3 2025), and $14.1 million (Q2 2025), per Business Quant data.

Peer Comparison